Delivery Order SPE2DB25D3012-SPE2DB25FWYWL
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $40,663.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML syringes on August 25, 2025, with completion targeted for August 26, 2025. This non-competed delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $24,366.80 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml syringes, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,794.36 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of July 31, 2025. The contract was executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $45,053.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. This non-competitive delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a small but specialized pharmaceutical procurement fulfilling federal medical supply requirements. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $38,306.42 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of SKYRIZI 600 mg/10 ml vials, valued at $12,239.38 with a firm fixed price structure. The delivery order is set to be completed by September 16, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $17,574.35 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen vials under a firm fixed price contract type. This competitive award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This firm fixed-price delivery order, valued at $11.83K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99M prime vendor agreement extending through December 2026. The delivery order carries no set-aside designation and requires...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,972.91 delivery order on August 19, 2025, for SKYRIZI 150 MG/ML pen/mL, a prescription biologic medication. This firm fixed price, competitively awarded contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12,962.95 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of SKYRIZI 150 mg/ml pen injections. This is a firm fixed-price contract with an ultimate completion date of July 28, 2025, and was competitively awarded with no set-aside designation. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYWLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $84,213.39 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml syringes on July 28, 2025. This firm fixed-price, competitively awarded delivery order is classified as non-set-aside and represents a child contract under AmerisourceBergen's larger prime Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which serves as a critical vehicle for federal medical procurement supporting military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies for the federal government. The SKYRIZI delivery represents the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers through its flexible contract vehicle arrangement with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $84.2k | 7/28/25 |